PL3324935T3 - Roztwór wodny zawierający stilbenoid - Google Patents

Roztwór wodny zawierający stilbenoid

Info

Publication number
PL3324935T3
PL3324935T3 PL16741615.5T PL16741615T PL3324935T3 PL 3324935 T3 PL3324935 T3 PL 3324935T3 PL 16741615 T PL16741615 T PL 16741615T PL 3324935 T3 PL3324935 T3 PL 3324935T3
Authority
PL
Poland
Prior art keywords
stilbenoid
aqueous solution
solution containing
aqueous
solution
Prior art date
Application number
PL16741615.5T
Other languages
English (en)
Inventor
Guido Grentzmann
Original Assignee
Opterion Health Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opterion Health Ag filed Critical Opterion Health Ag
Publication of PL3324935T3 publication Critical patent/PL3324935T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
PL16741615.5T 2015-07-20 2016-07-19 Roztwór wodny zawierający stilbenoid PL3324935T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15177541.8A EP3120838A1 (en) 2015-07-20 2015-07-20 Aqueous solution comprising a polyphenol
PCT/EP2016/067188 WO2017013121A1 (en) 2015-07-20 2016-07-19 Aqueous solution comprising a stilbenoid

Publications (1)

Publication Number Publication Date
PL3324935T3 true PL3324935T3 (pl) 2023-04-24

Family

ID=54007477

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16741615.5T PL3324935T3 (pl) 2015-07-20 2016-07-19 Roztwór wodny zawierający stilbenoid

Country Status (10)

Country Link
US (2) US20180214387A1 (pl)
EP (2) EP3120838A1 (pl)
JP (1) JP6505310B2 (pl)
CN (1) CN108601729B (pl)
DK (1) DK3324935T3 (pl)
ES (1) ES2929527T3 (pl)
PL (1) PL3324935T3 (pl)
PT (1) PT3324935T (pl)
RS (1) RS63867B1 (pl)
WO (1) WO2017013121A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202102243D0 (en) * 2021-02-17 2021-03-31 Royal Veterinary College New compounds and uses
EP4532458A4 (en) * 2022-06-02 2026-08-05 Univ Colorado Regents METHODS FOR MODULATING ENDONUCLEASE G USING RESVERATROL AND ITS DERIVATIVES
WO2025265015A1 (en) * 2024-06-20 2025-12-26 Barinta Therapeutics, Inc. Flavylium cations and electrolyte complexes thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050245612A1 (en) * 2004-05-03 2005-11-03 Blass John P Pharmaceutical compositions for metabolic insufficiencies
JP4801883B2 (ja) * 2004-04-22 2011-10-26 丸善製薬株式会社 ノブドウ抽出物組成物、ノブドウ抽出物含有飲食物、及びノブドウ抽出物の呈味改善方法
JP2006020506A (ja) * 2004-07-06 2006-01-26 Ichimaru Pharcos Co Ltd 水易溶解性セラミド配合飲食品
WO2007049796A2 (en) * 2005-10-26 2007-05-03 Kao Corporation Resveratrol and/or grape leaf extract as i. a. endurance improver, anti-aging agent, muscle strength improver
JP2008290982A (ja) * 2007-05-25 2008-12-04 Oriza Yuka Kk 水溶性スチルベン粉末製剤
JP5626809B2 (ja) * 2009-02-04 2014-11-19 ディーエスエム アイピー アセッツ ビー．ブイ． レスベラトロール組成物
WO2010135589A2 (en) * 2009-05-20 2010-11-25 Sakura Properties, Llc Dietary supplement drink for delivery of resveratrol and other polyphenols
JP5714311B2 (ja) * 2009-11-27 2015-05-07 ダイソー株式会社 水難溶性薬理活性物質の薬理活性を維持しながら水溶性を付与する方法
KR101138258B1 (ko) * 2009-12-09 2012-04-24 (주)바이오제닉스 올리고머 복합체의 형성을 통한 난/불용성 활성물질의 가용화 방법
JP5858686B2 (ja) * 2011-08-25 2016-02-10 花王株式会社 難水溶性ポリフェノール類の糖付加物の製造方法
EP2790531B1 (en) 2011-12-15 2022-01-19 Société des Produits Nestlé S.A. Cohesive thin liquids to promote safe swallowing in dysphagic patients
CA2870967C (en) * 2012-04-19 2021-07-13 Purdue Research Foundation Highly branched alpha-d-glucans
JP5285194B1 (ja) * 2013-04-22 2013-09-11 森永製菓株式会社 飲食品
JP6177213B2 (ja) * 2013-10-08 2017-08-09 株式会社フェース トランスレスベラトロール多糖体、その製造方法、及びそれを含む組成物
JP2015208241A (ja) * 2014-04-24 2015-11-24 三栄源エフ・エフ・アイ株式会社 健康食品
CN106793821B (zh) * 2014-08-29 2021-05-07 花王株式会社 含有难溶性多酚类的固体分散体的制造方法
JP6551921B2 (ja) * 2015-03-31 2019-07-31 公立大学法人大阪 可溶化剤

Also Published As

Publication number Publication date
DK3324935T3 (da) 2022-11-28
US11185514B2 (en) 2021-11-30
US20180214387A1 (en) 2018-08-02
JP2018521088A (ja) 2018-08-02
EP3324935A1 (en) 2018-05-30
PT3324935T (pt) 2022-11-04
ES2929527T3 (es) 2022-11-29
WO2017013121A1 (en) 2017-01-26
RS63867B1 (sr) 2023-01-31
CN108601729A (zh) 2018-09-28
US20200108026A1 (en) 2020-04-09
CN108601729B (zh) 2022-10-25
BR112017027350A2 (en) 2018-08-28
EP3324935B1 (en) 2022-10-19
HK1254524A1 (zh) 2019-07-19
JP6505310B2 (ja) 2019-04-24
EP3120838A1 (en) 2017-01-25

Similar Documents

Publication Publication Date Title
EP3348489A4 (en) CAP
DK3042686T3 (da) Indføringskappe
EP3723320C0 (en) SIMPLE RACH (SRACH)
PL3151327T3 (pl) Roztwór elektrolitu
DK3310675T3 (da) Dåselåg
DK3140353T3 (da) En coating opløsning
IL246447A0 (en) Pharmaceutical preparation containing pyridylaminoacetic acid compound
HUE047297T2 (hu) Tekercselõdob
DK3377417T3 (da) Dåselåg
EP3302376A4 (en) NASAL DILATORS
DK3102275T3 (da) Nasal dilatator
EP3305294A4 (en) AQUEOUS MEDICINE
EP3378798A4 (en) CRUSH CONTAINER
HUE048790T2 (hu) Vizes készítmény
DK3324935T3 (da) Vandig opløsning der omfatter et stilbenoid
IL249842A0 (en) Lipid comprising docosapentaenoic acid
EP3380144C0 (en) DRUG ADMINISTRATION DEVICES
EP3395344A4 (en) MEDICINE
DK3453388T3 (da) Farmaceutisk opløsning omfattende dopaminhydrochlorid
BR112016019617A2 (pt) Composição adesiva aquosa
EP3368527A4 (en) Palbociclib salts
UA32340S (uk) Ковпачок
UA32292S (uk) Ковпачок
UA32294S (uk) Ковпачок
UA31897S (uk) Ковпачок